Article
Human antibodies for immunotherapy development generated via a human B cell hybridoma technology
27 Feb 2006
Abstract excerpt
Current strategies for the production of therapeutic mAbs include the use of mammalian cell systems to recombinantly produce Abs derived from mice bearing human Ig transgenes, humanization of rodent Abs, or phage libraries. Generation of hybridomas secreting human mAbs has been previously reported; however, this approach has not been fully exploited for immunotherapy development. We previously reported the use of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
